8.13
                                            Schlusskurs vom Vortag:
              $8.20
            Offen:
              $8.24
            24-Stunden-Volumen:
                44,214
            Relative Volume:
              0.60
            Marktkapitalisierung:
                $226.92M
            Einnahmen:
              $21.25M
            Nettoeinkommen (Verlust:
              $-16.05M
            KGV:
              -13.33
            EPS:
                -0.61
            Netto-Cashflow:
                $-17.14M
            1W Leistung:
              -7.82%
            1M Leistung:
              -17.71%
            6M Leistung:
                +29.05%
            1J Leistung:
              +87.33%
            Fennec Pharmaceuticals Inc Stock (FENC) Company Profile
Firmenname
                  
                      Fennec Pharmaceuticals Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      (919) 636-4530
                    
                Adresse
                  
                      PO BOX 13628, RESEARCH TRIANGLE PARK, NC
                    
                Vergleichen Sie FENC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                FENC
                            
                             
                        Fennec Pharmaceuticals Inc 
                           | 
                    8.13 | 228.22M | 21.25M | -16.05M | -17.14M | -0.61 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2022-11-22 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight | 
| 2022-09-07 | Eingeleitet | CapitalOne | Overweight | 
| 2022-08-08 | Fortgesetzt | Craig Hallum | Buy | 
| 2020-06-05 | Eingeleitet | Cantor Fitzgerald | Overweight | 
| 2018-10-11 | Eingeleitet | Goldman | Buy | 
Fennec Pharmaceuticals Inc Aktie (FENC) Neueste Nachrichten
Is Fennec Pharmaceuticals Inc. stock a safe investment in uncertain markets2025 Market Overview & Community Consensus Picks - newser.com
Is Fennec Pharmaceuticals Inc. stock attractive for hedge fundsTrade Entry Report & High Accuracy Trade Alerts - newser.com
Will Fennec Pharmaceuticals Inc. (RV41) stock outperform Dow JonesInflation Watch & Risk Adjusted Swing Trade Ideas - newser.com
How to integrate Fennec Pharmaceuticals Inc. into portfolio analysis toolsEarnings Performance Report & Stepwise Entry and Exit Trade Signals - newser.com
How Fennec Pharmaceuticals Inc. (RV41) stock trades in high volatilityNew Guidance & Safe Entry Momentum Tips - newser.com
Can momentum traders help lift Fennec Pharmaceuticals Inc.Trade Analysis Report & Risk Controlled Daily Trade Plans - newser.com
Will a bounce in Fennec Pharmaceuticals Inc. offer an exitJuly 2025 Closing Moves & Safe Entry Zone Tips - newser.com
What hedge fund moves indicate for Fennec Pharmaceuticals Inc. (RV41) stock2025 Bull vs Bear & Safe Capital Growth Tips - newser.com
What is the fair value estimate for Fennec Pharmaceuticals Inc. (RV41) stock in 2025Weekly Gains Summary & Community Verified Swing Trade Signals - newser.com
Can Fennec Pharmaceuticals Inc. stock withstand economic slowdownEarnings Overview Summary & Real-Time Chart Pattern Alerts - newser.com
Can Fennec Pharmaceuticals Inc. stock maintain growth trajectory2025 Pullback Review & High Accuracy Trade Signal Alerts - newser.com
Developing predictive dashboards with Fennec Pharmaceuticals Inc. data2025 Technical Patterns & Smart Investment Allocation Insights - newser.com
How resilient is Fennec Pharmaceuticals Inc. stock in market downturns2025 Historical Comparison & AI Powered Buy and Sell Recommendations - newser.com
Is Fennec Pharmaceuticals Inc. (RV41) stock cheap by valuation metricsTrade Signal Summary & Consistent Profit Trade Alerts - newser.com
Using portfolio simulators with Fennec Pharmaceuticals Inc. includedTrade Signal Summary & Entry Point Strategy Guides - newser.com
Is Fennec Pharmaceuticals Inc. stock a top pick in earnings seasonDollar Strength & Growth Focused Investment Plans - newser.com
Is Fennec Pharmaceuticals Inc. stock ready for breakoutTrade Volume Summary & High Conviction Buy Zone Alerts - newser.com
What MACD and RSI say about Fennec Pharmaceuticals Inc.2025 Price Targets & Safe Entry Trade Signal Reports - newser.com
Does Fennec Pharmaceuticals Inc. stock trade at a discount to peers2025 Trading Volume Trends & Accurate Entry/Exit Alerts - newser.com
Identifying reversal signals in Fennec Pharmaceuticals Inc.2025 Earnings Impact & Reliable Price Action Trade Plans - newser.com
Why Fennec Pharmaceuticals Inc. stock remains undervaluedProduct Launch & Free Community Supported Trade Ideas - newser.com
How buyback programs support Fennec Pharmaceuticals Inc. (RV41) stockWeekly Market Summary & Safe Capital Allocation Plans - newser.com
Fennec Pharmaceuticals Inc expected to post a loss of 2 cents a shareEarnings Preview - TradingView
Fennec Pharmaceuticals (TSE:FRX) Stock Price Passes Below 50 Day Moving AverageTime to Sell? - MarketBeat
Will earnings trigger a reversal in Fennec Pharmaceuticals Inc.Take Profit & Weekly High Conviction Trade Ideas - newser.com
Can Fennec Pharmaceuticals Inc. (RV41) stock sustain double digit ROEEarnings Miss & Low Drawdown Trading Techniques - newser.com
Reversal indicators forming on Fennec Pharmaceuticals Inc. stockEarnings Recap Summary & Consistent Income Trade Ideas - newser.com
Advanced analytics toolkit walkthrough for Fennec Pharmaceuticals Inc.Quarterly Earnings Report & Low Risk High Reward Trade Ideas - newser.com
Finanzdaten der Fennec Pharmaceuticals Inc-Aktie (FENC)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):